1. Home
  2. RKT vs NVAX Comparison

RKT vs NVAX Comparison

Compare RKT & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RKT

Rocket Companies Inc.

HOLD

Current Price

$14.37

Market Cap

44.0B

Sector

Finance

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.77

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RKT
NVAX
Founded
1985
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.0B
1.6B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
RKT
NVAX
Price
$14.37
$9.77
Analyst Decision
Buy
Hold
Analyst Count
15
9
Target Price
$20.93
$11.33
AVG Volume (30 Days)
25.6M
4.5M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
N/A
$1,123,479,000.00
Revenue This Year
$66.62
N/A
Revenue Next Year
$7.79
N/A
P/E Ratio
N/A
$3.71
Revenue Growth
N/A
64.69
52 Week Low
$10.94
$5.01
52 Week High
$24.36
$11.85

Technical Indicators

Market Signals
Indicator
RKT
NVAX
Relative Strength Index (RSI) 38.48 50.04
Support Level $13.18 $7.81
Resistance Level $15.12 $10.42
Average True Range (ATR) 0.72 0.59
MACD -0.01 -0.13
Stochastic Oscillator 28.20 32.74

Price Performance

Historical Comparison
RKT
NVAX

About RKT Rocket Companies Inc.

Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit. Rocket Companies offers a wide array of services and products but is best known for its Rocket Mortgage business. The company's mortgage lending operations are split between its direct-to-consumer lending, which sees borrowers accessing the company's lending arm directly through either its mobile app or website, and its partner network where mortgage brokers and other firms use Rocket's origination process to offer loans to their customers. The company has rapidly gained market share in recent years and will also be the largest mortgage servicer in the US following its acquisition of the Mr. Cooper Group.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: